Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. COYA
COYA logo

COYA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Coya Therapeutics Inc (COYA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
4.810
1 Day change
-0.62%
52 Week Range
7.750
Analysis Updated At
2026/05/22
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

COYA is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The technical picture is mildly positive, but the lack of recent news, no strong proprietary buy signal, neutral insider/hedge fund activity, and no usable financial snapshot make this an uncertain entry for a long-term buy. Based on the data provided, I would not call it a clear buy today; a hold is the better decision until stronger fundamentals or a clearer catalyst appears.

Technical Analysis

COYA is trading at 4.855, slightly above the previous close of 4.84, with a regular-session gain of 4.76%. The MACD histogram is positive and expanding, which supports short-term bullish momentum. RSI_6 at 60.1 is neutral-to-mildly bullish, not overbought. Moving averages are converging, suggesting the stock is at a decision point rather than in a strong trend. Key levels: pivot 4.628, resistance 1 at 5.188, support 1 at 4.068. The near-term setup is constructive, but not strong enough to justify an aggressive long-term buy on technicals alone.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is bullish-to-neutral. Call open interest is 807 versus put open interest of 1, producing an extremely low put-call ratio of 0.0. Option volume also favors calls heavily, with a put-call ratio of 0.13. Volume today was 34, above the 30-day average, and open interest activity is elevated versus average. However, implied volatility is very high at 270.89, so options activity suggests speculative bullish interest rather than strong conviction from the broader market.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
6

Positive Catalysts

  • ["Positive MACD momentum", "Recent price gain and mild bullish tone in trading", "Strong call-heavy options positioning", "Stock pattern data suggests a 70% chance of short-term upside over the next day/week/month windows"]

Neutral/Negative Catalysts

  • ["No news in the recent week", "No recent AI Stock Picker or SwingMax signal", "Hedge funds are neutral", "Insiders are neutral", "No recent congress trading data", "Financial snapshot unavailable, so fundamental momentum cannot be confirmed", "High implied volatility may indicate speculative trading rather than durable demand"]

Financial Performance

No quarterly financial snapshot was available because the data returned an error, so there is no reliable latest-quarter revenue or earnings trend to assess. For a beginner long-term investor, the absence of recent financial visibility is a major limitation because the investment case cannot be grounded in confirmed growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no evidence of a recent upgrade/downgrade trend or meaningful Wall Street target movement to support a buy case. The current Wall Street view cannot be confirmed from the available data, and the absence of analyst momentum keeps the stock from qualifying as a clear long-term buy.

Wall Street analysts forecast COYA stock price to rise
3 Analyst Rating
Wall Street analysts forecast COYA stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 4.710
sliders
Low
16
Averages
17
High
18
Current: 4.710
sliders
Low
16
Averages
17
High
18
Lake Street
Buy
maintain
$16 -> $17
AI Analysis
2025-11-05
Reason
Lake Street
Price Target
$16 -> $17
AI Analysis
2025-11-05
maintain
Buy
Reason
Lake Street raised the firm's price target on Coya Therapeutics to $17 from $16 and keeps a Buy rating on the shares after the company released preclinical in vivo neuroinflammation data for COYA-303 consistent with earlier in vitro preclinical results released by Coya.
Lake Street
NULL -> Buy
initiated
$16
2025-07-09
Reason
Lake Street
Price Target
$16
2025-07-09
initiated
NULL -> Buy
Reason
Lake Street initiated coverage of Coya Therapeutics with a Buy rating and $16 price target. The firm says the company's anti-inflammation platform utilizes a disease pathway agnostic approach to increase the number and function of regulatory T cells. The evidence supporting a therapeutic anti-inflammatory benefit of Coya's low dose IL-2 is strong, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for COYA
Unlock Now

People Also Watch